In-silico Antimalarial Study of Monocarbonyl Curcumin Analogs and Their 2,4-Dinitro Phenylhydrazones Using the Inhibition of Plasmepsin II as Test Model

Olatomide A. Fadare; Ezekiel O.Iwalewa; Craig A. Obafemi; Feyisola P. Olatunji

Journal ArticleOPEN ACCESS

In-silico Antimalarial Study of Monocarbonyl Curcumin Analogs and Their 2,4-Dinitro Phenylhydrazones Using the Inhibition of Plasmepsin II as Test Model

A. Fadare O
O.Iwalewa E
A. Obafemi C
et al.

American Journal of Pharmacological Sciences (2017) 5(2) 18-24

DOI: 10.12691/ajps-5-2-1

N/ACitations

11Readers

Abstract

… It is thought that if the analogs of curcumin are more bioavailable and have … Q. “Improving the Oral bioavailability of Curcumin Using Novel Organogel-based Nanoemulsions … MK, Choi, HK “Preparation and Pharmacokinetic Evaluation of Curcumin Solid Dispersion using Solutol …

Cite

CITATION STYLE

APA

A. Fadare, O., O.Iwalewa, E., A. Obafemi, C., & P. Olatunji, F. (2017). In-silico Antimalarial Study of Monocarbonyl Curcumin Analogs and Their 2,4-Dinitro Phenylhydrazones Using the Inhibition of Plasmepsin II as Test Model. American Journal of Pharmacological Sciences, 5(2), 18–24. https://doi.org/10.12691/ajps-5-2-1

In-silico Antimalarial Study of Monocarbonyl Curcumin Analogs and Their 2,4-Dinitro Phenylhydrazones Using the Inhibition of Plasmepsin II as Test Model

Abstract

Cite

Register to see more suggestions